University of Florida chemists are the first to use a new tool to identify the molecular signatures of serious diseases -- without any previous knowledge of what these microscopic signatures or “biomarkers” should look like. The advance could one day lead to earlier detection and improved treatment of some types of cancer as well as other diseases.
